PNTG — The Pennant Group, Inc.

Summary of The Pennant Group Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Revenue: $285.4 million, up $75.5 million (36%) year-over-year.
• Adjusted EBITDA: $21.7 million, an increase of $5.3 million (32.6%).
• Adjusted EBITDA (prior to NCI): $23.5 million, up $6.4 million (37.2%).
• Adjusted Diluted EPS: $0.32, an increase of $0.05 (18.5%).
• GAAP Net Income: $8.5 million, up $0.7 million (9.6%).
• Cash Flow: Cash used in operations improved by $17.8 million year-over-year to $3.4 million.
• Debt: $170.8 million outstanding under credit facilities, with a net debt to adjusted EBITDA ratio of 1.93x.

2. Strategic Updates and Business Highlights

• Continued focus on operational excellence and leadership development, with 47 new CEOs in training added in 2026.
• Successful integration of operations from UnitedHealthcare in Tennessee, Alabama, and Georgia, with two of five operational waves fully transitioned.
• Home Health and Hospice segment revenue increased by 43.3% to $229.1 million, with significant growth in admissions.
• Hospice average daily census rose by 37%, and same-store hospice admissions grew by 10.2%.
• Senior Living segment revenue increased by 12.6% to $56.3 million, with adjusted EBITDA margin improving to 11.8%.
• Completed four acquisitions in Senior Living post-quarter end, enhancing presence in strategic markets.

3. Forward Guidance and Outlook

• No changes to full-year guidance, but management indicated a positive outlook, pointing to the upper end of guidance range.
• Anticipated improvements in operational performance as the transition from UnitedHealthcare continues, with expectations for margin improvement as transition services costs roll off.
• Continued focus on growth through tuck-in acquisitions and joint ventures with integrated healthcare systems.

4. Bad News, Challenges, or Points of Concern

• Transitioning more than 50 new operations has temporarily increased costs and impacted margins.
• Seasonal admission trends and severe weather events in January posed challenges, although census has rebounded.
• Competitive pressures in the Home Health market, particularly regarding Medicare admissions and CAP management, with potential risks from increased competition for short-stay admissions.
• Ongoing labor pressures and macroeconomic factors, including rising fuel costs, could impact operational costs.

5. Notable Q&A Insights

• Integration of Amedisys United assets is progressing well, with expectations for improved margins as transition services costs decrease.
• The company is actively engaging with payers in the Southeast, seeing positive results in contract negotiations.
• The focus on compliance and addressing fraud, waste, and abuse is viewed as an opportunity to gain market share as underperforming competitors are weeded out.
• Management remains cautious about declaring victory in integration efforts, preferring to observe results over the next quarter before making adjustments to guidance.

Overall, Pennant Group reported strong financial performance in Q1 2026, with robust growth in both Home Health and Senior Living segments, while navigating challenges related to integration and market competition. The company maintains a positive outlook for the remainder of the year, emphasizing operational improvements and strategic growth initiatives.